Literature DB >> 19494726

Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.

Eduardo A De Sousa1, Russell L Chin, Howard W Sander, Norman Latov, Thomas H Brannagan.   

Abstract

OBJECTIVE: The objective of this study was to evaluate how the number of demyelinating findings (DF) on nerve conductions affects sensitivity and specificity of electrodiagnostic criteria for chronic inflammatory demyelinating polyneuropathy (CIDP).
METHODS: Electrodiagnostic findings of 26 consecutive patients with CIDP were compared with amyotrophic lateral sclerosis (ALS) and diabetic polyneuropathy controls. Patients with CIDP were divided into typical and atypical CIDP, as defined elsewhere.
RESULTS: Depending on the minimal required number (MRN) of DF on nerve conductions, sensitivities decreased from an arbitrary 100% to 58% and 54%, for an MRN of 1, 2, and 3, respectively, as specificities increased, from 48% to 81% and 95%, respectively. The number of DF per patient was higher in typical CIDP than in atypical CIDP.
CONCLUSIONS: The considerable gap between specificity and sensitivity is the reason for controversy regarding the MRN for the diagnosis of CIDP. Requiring 2 or more DFs to identify CIDP increases specificity from 48% to 81% but lowers sensitivity from 100% to 58%. For patients with other potential causes of neuropathy, the requirement of 2 or more DFs could further increase specificity.

Entities:  

Mesh:

Year:  2009        PMID: 19494726     DOI: 10.1097/CND.0b013e31819a71e1

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  9 in total

Review 1.  Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.

Authors:  James W Albers; Rodica Pop-Busui
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

Review 2.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 3.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

4.  A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples.

Authors:  Seigo Usuki; Dawn O'Brien; Michael H Rivner; Robert K Yu
Journal:  J Immunol Methods       Date:  2014-05-23       Impact factor: 2.303

5.  A patient with amyotrophic lateral sclerosis and atypical clinical and electrodiagnostic features: a case report.

Authors:  Alexander Venizelos; Youngsook Park; Morris A Fisher
Journal:  J Med Case Rep       Date:  2011-11-02

6.  Electrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and charcot-marie-tooth type 1: dispersion and correlation analysis.

Authors:  Ji Hyuk Kang; Hye Jeong Kim; Eun Ryeong Lee
Journal:  J Phys Ther Sci       Date:  2013-11-20

7.  Chronic inflammatory demyelinating polyradiculoneuropathy: A case report.

Authors:  Bolin Hu; Yibiao Zhou; Xiaoqing Lu; Qianqian Xiong; Qing Liu; Xueliang Qi; Weijiang Ding
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes.

Authors:  Ari Breiner; Carolina Barnett Tapia; Leif Erik Lovblom; Bruce A Perkins; Hans D Katzberg; Vera Bril
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-07-10

9.  Leukocyte-derived microparticles and scanning electron microscopic structures in two fractions of fresh cerebrospinal fluid in amyotrophic lateral sclerosis: a case report.

Authors:  Anne C Zachau; Mikael Landén; Fariborz Mobarrez; Rolf Nybom; Håkan Wallén; Lennart Wetterberg
Journal:  J Med Case Rep       Date:  2012-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.